Structural characterization of LRRK2 inhibitors

Keyphrases

• Structural Characterization 100%
• Leucine-rich Repeat Kinase 2 (LRRK2) 100%
• LRRK2 Inhibitors 100%
• Dictyostelium 33%
• Parkinson's Disease 33%
• Active Sites 33%
• Structure Function 33%
• Therapeutic Target 33%
• NMR Spectroscopy 33%
• X-ray Crystallography 33%
• Kinase Inhibition 33%
• Co-crystal Structure 33%
• Drug Candidates 33%
• LRRK2 Kinase Inhibitor 33%
• Saturation Transfer Difference NMR 33%
• Structural Optimization 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Phosphotransferase 100%
• Dictyostelium 50%
• Phosphotransferase Inhibitor 50%
• Parkinson's Disease 50%
• Diseases 50%

Biochemistry, Genetics and Molecular Biology

• LRRK2 100%
• Phosphotransferase 50%
• Kinase 50%
• Dictyostelium 16%
• Active Site 16%
• X-Ray Crystallography 16%
• Nuclear Magnetic Resonance Spectroscopy 16%
• Saturation Transfer 16%